Literature DB >> 29270841

Trends in Racial/Ethnic Disparities Among Patients Living with HIV in Texas, 1996 to 2013.

Sabina O Nduaguba1, Kentya H Ford2, James P Wilson1, Kenneth A Lawson1.   

Abstract

National studies show that Blacks with HIV have higher mortality rates compared to Whites. This study aimed to identify trends in Black racial disparities among Texas residents living with HIV. Using HIV surveillance data from the Texas Department of State Health Services, a cohort of HIV-diagnosed patients (N = 70,996) were identified and grouped according to year of diagnosis, 1996-1997 (T1), 1998-2006 (T2), 2007-2010 (T3), and 2011-2013 (T4). Survival analysis was used to examine racial differences in death rate (analysis 1) and clinical progression to AIDS (analysis 2) for each subcohort, using Blacks as the reference group. In analysis 1, Whites (hazard ratio, HR = 0.80, 95% confidence interval, CI = 0.74-0.87, p < 0.001; HR = 0.82, 95% CI = 0.78-0.87, p < 0.001; respectively) and Hispanics (HR = 0.72, 95% CI = 0.66-0.79, p < 0.001; HR = 0.77, 95% CI = 0.74-0.81, p < 0.001, respectively) had lower death rates in T1 and T2. This remained significant after adjusting for covariates. In T3, death rate was higher for Hispanics after adjustment (HR = 1.13, 95% CI = 1.00-1.28, p < 0.05). In T4, death rate was higher for Whites (HR = 1.66, 95% CI = 1.30-2.13, p < 0.001) and Hispanics (HR = 1.66, 95% CI = 1.34-2.06, p < 0.001). These relationships became non-significant after adjusting for covariates. In analysis 2, the rate of clinical progression to AIDS was higher for Hispanics in all subcohorts. The significance remained after adjusting for covariates. The rate of clinical progression to AIDS was lower for Whites after adjustments in T2 and T3. Additional studies are needed to understand factors that may explain this unexpected finding of improved survival for Blacks over time. Such studies may inform decision-making in HIV care to reduce Black HIV disparities.

Entities:  

Keywords:  HIV; Racial disparities; Survival analysis; Time trend

Mesh:

Year:  2017        PMID: 29270841     DOI: 10.1007/s40615-017-0450-1

Source DB:  PubMed          Journal:  J Racial Ethn Health Disparities        ISSN: 2196-8837


  35 in total

1.  Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).

Authors:  Mark Holodniy; John Hornberger; Dana Rapoport; Katherine Robertus; Thomas E MaCurdy; Jude Lopez; Paul Volberding; Lawrence Deyton
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

2.  Black:White Disparities in HIV Mortality in the United States: 1990-2009.

Authors:  Kristi L Allgood; Bijou Hunt; Monique Glover Rucker
Journal:  J Racial Ethn Health Disparities       Date:  2015-07-07

3.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; Jose M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; Stefano Vella; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

4.  Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

Authors:  Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews
Journal:  J Acquir Immune Defic Syndr       Date:  2005-01-01       Impact factor: 3.731

5.  Understanding disparities in HIV infection between black and white MSM in the United States.

Authors:  Alexandra M Oster; Ryan E Wiegand; Catlainn Sionean; Isa J Miles; Peter E Thomas; Lehida Melendez-Morales; Binh C Le; Gregorio A Millett
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

6.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.

Authors:  Eileen Schneider; Suzanne Whitmore; Kathleen M Glynn; Kenneth Dominguez; Andrew Mitsch; Matthew T McKenna
Journal:  MMWR Recomm Rep       Date:  2008-12-05

7.  Examining geographic and temporal variations of AIDS mortality: evidence of racial disparities.

Authors:  Yu-Wen Chiu; Chiehwen Ed Hsu; Min-Qi Wang; Ella T Nkhoma
Journal:  J Natl Med Assoc       Date:  2008-07       Impact factor: 1.798

8.  A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

Authors:  K Henry; A Erice; C Tierney; H H Balfour; M A Fischl; A Kmack; S H Liou; A Kenton; M S Hirsch; J Phair; A Martinez; J O Kahn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-01

9.  Natural history of HIV-1 cell-free viremia.

Authors:  D R Henrard; J F Phillips; L R Muenz; W A Blattner; D Wiesner; M E Eyster; J J Goedert
Journal:  JAMA       Date:  1995-08-16       Impact factor: 56.272

10.  Mortality among blacks or African Americans with HIV infection--United States, 2008-2012.

Authors:  Azfar-e-Alam Siddiqi; Xiaohong Hu; H Irene Hall
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-06       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.